| Literature DB >> 30465800 |
Janaína F Barros1, Ingrid Waclawiak2, Cyntia Pecli1, Paula A Borges1, Janaína L Georgii1, Erivan S Ramos-Junior2, Claudio Canetti2, Tristan Courau3, David Klatzmann4, Steven L Kunkel5, Carmen Penido6, Fábio B Canto7, Claudia F Benjamim8.
Abstract
Wound healing is a well-coordinated process that involves inflammatory mediators and cellular responses; however, if any disturbances are present during this process, tissue repair is impaired. Chronic wounds are one of the serious long-term complications associated with diabetes mellitus. The chemokine receptor CCR4 and its respective ligands, CCL17 and CCL22, are involved in regulatory T cell recruitment and activation in inflamed skin; however, the role of regulatory T cells in wounds is still not clear. Our aim was to investigate the role of CCR4 and regulatory T cells in cutaneous wound healing in diabetic mice. Alloxan-induced diabetic wild- type mice (diabetic) developed wounds that were difficult to heal, differently from CCR4-/- diabetic mice (CCR4-/- diabetic), and also from anti-CCL17/22 or anti-CD25-injected diabetic mice that presented with accelerated wound healing and fewer regulatory T cells in the wound bed. Consequently, CCR4-/- diabetic mice also presented with alteration on T cells population in the wound and draining lymph nodes; on day 14, these mice also displayed an increase of collagen fiber deposition. Still, cytokine levels were decreased in the wounds of CCR4-/- diabetic mice on day 2. Our data suggest that the receptor CCR4 and regulatory T cells negatively affect wound healing in diabetic mice.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30465800 DOI: 10.1016/j.jid.2018.10.039
Source DB: PubMed Journal: J Invest Dermatol ISSN: 0022-202X Impact factor: 8.551